½ÉÀå´ë»çÁõÈıºÇÐȸ 2024 7th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS (1ÀÏÂ÷) : 2024-04-26
±³À°ÀÏÀÚ : 2024-04-26
±³À°Àå¼Ò : Conrad Hotel Seoul (5F PARK BALLROOM)

±³À°ÁÖÁ¦ : 2024 7th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS (1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀå´ë»çÁõÈıºÇÐȸ

´ã´çÀÚ : ±è¼±¿Á
¿¬¶ôó : 02-717-8977

À̸ÞÀÏ : apcms@kscms.org

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 16 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 140,000¿ø  

ºñ°í Àü¹®ÀÇ,±³¼ö: ȸ¿ø 120000, ºñȸ¿ø 140000ÀüÀÓÀÇ,Àü°øÀÇ,±ºÀÇ°ü,°øº¸ÀÇ,¿¬±¸¿ø,°£È£»ç,¿µ¾ç»ç,¾à»ç,±â¾÷ȸ¿ø,±âŸ: 60000

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1 08:30~08:40 (Abstract) Circadian variation of blood Pressure as early early predictor of antracycline induced cardiotoxixcity Shipra Bhardwaj(India)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1 08:40~08:50 (Abstract) A proof-of-concept study of the relation between left atrial elastance and pulmonary hypertension in atrial fibrillation: diastolic elastance index À念¿ì(°¡ÃµÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1 08:50~09:00 (Abstract) TRF Intervention Alters the Epigenetic Modification of High Fat Diet Induced Obese Rats Nazmin Fatima(King George)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1 09:00~09:10 (Abstract) Renal Hyperfiltration as a Risk Factor of Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction ±è¿ø(°æÈñÀÇ´ë)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1 09:10~09:20 (Abstract) Text-Based Forecasting of Heart Disease Using Artificial Intelligence: A Deep Learning Approach Jakir Hossain Bhuiyan Masud(Public Health Informatics Foundation)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1 09:20~09:30 (Abstract) Glycemic Status and Risk of Incident Dementia in Patients with Myocardial Infarction õ´ë¿µ(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1 09:30~09:40 (Abstract) Mitigation of hepatic steatosis and dyslipidemia by hesperidin in high-fat high fructose diet via al altering genes expression related to lipid metabolism Deepika Singh(SHUATS)

Åä·Ð 04¿ù 26ÀÏ Room 1 09:40~09:50 Discussion ¼­Áö¿ø(¿¬¼¼ÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1 10:10~10:30 Pleiotropic Effect of GLP-1 Based Therapy Beyond the Glucose Control Á¤Ã¢Èñ(¿ï»êÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1 10:30~10:50 New Dual GIP/GLP-1 Receptor Agonists: The Role of GIP È«ÁØÈ­(À»ÁöÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1 10:50~11:10 Clinical Application of GLP-1 Receptor Agonist in Real World ¼­¹ÌÇý(¼øõÇâÀÇ´ë ³»ºÐºñ³»°ú)

Åä·Ð 04¿ù 26ÀÏ Room 1 11:10~11:30 Discussion À±Á¾Âù(°¡Å縯ÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1 16:50~17:05 Current Status for Dyslipidemia Management in Patients with Acute Myocardial Infarction in Korea: Insight from Korea AMI Registry ÀÌÀåÈÆ(°æºÏÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1 17:05~17:20 The Function of Gut Microbiota in the Effectiveness and Adverse Effects of Lipid-lowering Therapies Jianqing She(First Affiliated Hospital of Xi)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1 17:20~17:35 Impact of Organokines on Insulin Resistance, Inflammataion, and Atherosclerosis Ãְ湬(°í·ÁÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1 17:35~17:50 Perirenal Adipose Afferent Nerves Sustain Pathological High Blood Pressure in Rats Xiangqing Kong(The First Affiliated Hospital of Nanjing Medical Univ.)

Åä·Ð 04¿ù 26ÀÏ Room 1 17:50~18:10 Discussion ¼­´ÙÇý(ÀÎÇÏÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 2 08:30~08:45 Association Between Serum Adropin Level and Cardiac Target Organ Damages ±èÇзÉ(¼­¿ïÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 2 08:45~09:00 Association Between Fasting Glucose and Cardiovascular Disease Á¤¹ÌÇâ(°¡Å縯ÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 2 09:00~09:15 Impact of Atrial Function on the Prognosis of Patients with Atrial Fibrillation and Metabolic Syndrome ±èÇöÁø(ÇѾçÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 2 09:15~09:30 Cholesterol Variability as a Potential Residual Cardiovascular Risk Factor in the Elderly ÁÖÇüÁØ(°í·ÁÀÇ´ë ¼øȯ±â³»°ú)

Åä·Ð 04¿ù 26ÀÏ Room 2 09:30~09:50 Discussion Á¤ÀçÈÆ(µ¿±¹ÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 2 10:10~10:30 Mitochondrial Implantation for the Treatment of Cardiovascular Diseases ÀåÀºÈ­(¼­¿ïÀÇ´ë »ý¸®Çб³½Ç)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 2 10:30~10:50 Discovering Novel Biomarkers in Atherosclerosis ±¸À¯Á¤(¼­¿ïÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 2 10:50~11:15 Mitochondrial DNA Editing in Vitro and in Vivo ±èÁø¼ö(National University of Singapore)

Åä·Ð 04¿ù 26ÀÏ Room 2 11:15~11:30 Discussion À念¿ì(°¡ÃµÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 2 16:50~17:10 Glucose Continuous Monitoring for Stroke Patients ±èÄ¡°æ(°í·ÁÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 2 17:10~17:30 Glucose Control with Ischemic Stroke Patients: Should We Consider the Stroke Subtype? ±è¹üÁØ(¿ï»êÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 2 17:30~17:50 Rapid Lowering LDL-C in the Acute Stage of Stroke ±ÇÇõ¼º(ÇѾçÀÇ´ë ½Å°æ°ú)

Åä·Ð 04¿ù 26ÀÏ Room 2 17:50~18:10 Discussion ÇÏ»óÈñ(°¡ÃµÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 3 08:30~08:45 Mediterranean Diet and CardioMetabolic Health: Insights from Epidemiological and Clinical Studies ÀÌÀº¹Ì(¿ø±¤ÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 3 08:45~09:00 DASH Diet and CardioMetabolic Health: Clinical Applications and Limitations À±ÇöÁÖ(Àü³²ÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 3 09:00~09:15 Phytochemical Rich Diet and CardioMetabolic Health ¹Ú°æ(¿µ³²´ë ½ÄÇ°¿µ¾çÇаú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 3 09:15~09:30 Comparative Analysis of Traditional Diets: Implications for CardioMetabolic Diseases Prevention and Management ±è¿øÁø(Â÷ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú)

Åä·Ð 04¿ù 26ÀÏ Room 3 09:30~09:50 Discussion ±¸À¯Á¤(¼­¿ïÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 3 10:10~10:30 Appropriate Exercise Prescription for Cardiometabolic Disease ÀÌÁ¤¾Æ(°æÈñ´ë üÀ°´ëÇпø ½ºÆ÷Ã÷ÀÇ°úÇÐ)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 3 10:30~10:50 What is an Appropriate Exercise Prescription for the Elderly and Frail Population? ¼ºÁöµ¿(¼º±Õ°üÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 3 10:50~11:10 Physical Activity, Exercise, and Non-alcoholic Fatty Liver Disease Á¶Áø°æ(¼º±Õ°ü´ë ½ºÆ÷Ã÷°úÇаú)

Åä·Ð 04¿ù 26ÀÏ Room 3 11:10~11:30 Discussion ÀÌÁ¾¿µ(¼º±Õ°üÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 3 15:00~15:15 Mobile and Wearable Sensing for Personalized CMS Management ÀÌÀÇÁø(KAIST Àü»êÇкÎ)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 3 15:15~15:30 Mobile APPs and Patient Engagement: Empowering CMS Self-management À̸¸°æ(¼º±Õ°ü´ë »ï¼ºÀ¶ÇÕÀÇ°úÇпø)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 3 15:30~15:45 Digital Therapeutics: Prospects and Challenges for CMS Patients Á¶ÀçÇü(°¡Å縯ÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 3 15:45~16:00 Artificial Intelligence in CMS Care: Current Applications & Future Expansions Â÷¿øö(¼º±Õ°üÀÇ´ë ÀÀ±ÞÀÇÇаú)

Åä·Ð 04¿ù 26ÀÏ Room 3 16:00~16:10 Discussion ¹Ú»ó¹Î(À»ÁöÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 3 16:50~17:10 Unraveling the Link: CardioMetabolic Health and Mental Stress Management ÀÌ»óÁø(¼­¿ïÀÇ´ë ÀÇ»ý¸í¿¬±¸¿ø)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 3 17:10~17:30 Restoring Balance: The Role of Sleep in Cardiometabolic Health and Intervention Strategies Á¶Ã¶Çö(°í·ÁÀÇ´ë Á¤½Å°Ç°­ÀÇÇаú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 3 17:30~17:50 Meditation and Mindfulness for CardioMetabolic Health Á¶¼ºÁØ(¼º±Õ°üÀÇ´ë Á¤½Å°Ç°­ÀÇÇаú)

Åä·Ð 04¿ù 26ÀÏ Room 3 17:50~18:10 Discussion ÇÏ»óÁø(µ¿¼ö¿øº´¿ø ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1+2 15:00~15:30 Residual Risk: TRL, Remnant Cholesterol, and non-HDLC in ASCVD Pia R. Kamstrup(Copenhagen Univ. Hospital – Herlev Gentofte)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1+2 15:30~16:00 Vaso-protection of PPARs Activation in Cardio-metabolic Disease Yu Huang(City Univ. of Hong Kong)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1+2 16:00~16:30 Senolysis and the Suppression of Senocules Become Therapies for Cardiovascular-metabolic Diseases Ippei Shimizu(National Cerebral and Cardiovascular Center)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1+2+3 13:00~13:30 Triglyceride, Remnant Cholesterol and Cardiovascular Disease: What Is New? Á¶»óÈ£(ÇѸ²ÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1+2+3 13:30~14:10 Lipoprotein(a): An Important Risk Factors for ASCVD on Its Way into Clinical Practice Florian Kronenberg(Medical Univ. of Innsbruck)

±³À°½Ã°£ 04¿ù 26ÀÏ Room 1+2+3 14:10~14:50 Recent Therapeutic Perspectives in Cardiometabolic Disorders: From Lipid and Atherosclerosis to ASCVD Stephen J. Nicholls(Monash Health)